Personalized therapy: can it tame the COVID-19 monster?
Per Med
; 18(6): 583-593, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1526743
ABSTRACT
SARS-CoV-2, a recently emerged zoonotic virus, has resulted in unstoppable high morbidity and mortality rates worldwide. However, due to a limited knowledge of the dynamics of the SARS-CoV-2 infection, it has been observed that the current COVID-19 therapy has led to some clinical repercussions. We discuss the adverse effects of drugs for COVID-19 primarily based on some clinical trials. As therapeutic efficacy and toxicity of therapy may vary due to different, genetic determinants, sex, age and the ethnic background of test subjects, hence biomarker-based personalized therapy could be more appropriate. We will share our thoughts on the current landscape of personalized therapy as a roadmap to fight against SARS-CoV-2 or another emerging pathogen.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Precision Medicine
/
COVID-19
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Per Med
Year:
2021
Document Type:
Article
Affiliation country:
Pme-2021-0077
Similar
MEDLINE
...
LILACS
LIS